Pace Analytical Life Sciences FDA Inspection Record

FEI 3006500621 · Inspections, Form 483s, warning letters and import refusals

Pace Analytical Life Sciences is an FDA-inspected facility (FEI 3006500621) located in Salem, NH, US. RegDataLab tracks 9 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Sep 12, 2019: No Action Indicated (NAI)
Inspections on record
9 (6 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Sep 12, 2019No Action Indicated (NAI)No citations listed
Oct 26, 2018No Action Indicated (NAI)No citations listed
Oct 31, 2016Voluntary Action Indicated (VAI)Records not made readily available to FDA (21 CFR 211.180(c))
Calibration - at intervals, written program, remedial action (21 CFR 211.160(b)(4))
Written record of investigation incomplete (21 CFR 211.192)
Oct 22, 2014No Action Indicated (NAI)No citations listed
Jan 10, 2013Voluntary Action Indicated (VAI)Product flow through building is inadequate (21 CFR 211.42(b))
Written procedures not established/followed (21 CFR 211.67(b))
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Investigations of discrepancies, failures (21 CFR 211.192)
and 1 more
Oct 7, 2011Voluntary Action Indicated (VAI)Defined areas of adequate size for operations (21 CFR 211.42(c))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Procedures for sterile drug products (21 CFR 211.113(b))
Validation lacking for sterile drug products (21 CFR 211.113(b))
and 7 more
Aug 16, 2011Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Apr 23, 2010Voluntary Action Indicated (VAI)Following/documenting laboratory controls (21 CFR 211.160(a))
Written program not followed (21 CFR 211.166(a))
Test method modification records not maintained (21 CFR 211.194(b))
Stability testing records not included (21 CFR 211.194(e))
and 1 more
May 14, 2009Voluntary Action Indicated (VAI)Training , Education , Experience overall (21 CFR 211.25(a))
Investigations of discrepancies, failures (21 CFR 211.192)
Storage under appropriate conditions (21 CFR 211.142(b))

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIOct 31, 201610 years or older, so it adds no points0
Inspection classified VAIJan 10, 201310 years or older, so it adds no points0
Inspection classified VAIOct 7, 201110 years or older, so it adds no points0
Inspection classified VAIAug 16, 201110 years or older, so it adds no points0
Inspection classified VAIApr 23, 201010 years or older, so it adds no points0
Inspection classified VAIMay 14, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Pace Analytical Life Sciences as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Pace Analytical Life Sciences yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Pace Analytical Life Sciences
Location
Salem, NH (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.